MedTech market access and procurement models are evolving rapidly. Join this critical forum to unpack Discovery Health’s HTA decision-making process, the realities of Value-Based Procurement, and how data can unlock competitive advantage in a changing reimbursement environment.

Programme

10:00 – 11:00: Discovery Health HTA: Methodology, Decisions & Market Access Implications
Speaker: Susan Brandt – Clinical Researcher, Discovery Health

11:00 – 12:00: Value-Based Procurement: A Key Enabler of Value-Based Healthcare (Part 1)
Speaker: Brian Mangan – CEO, Luach Consulting Group

Gain an understanding of:

• The concept of value-based procurement and how it aligns to the delivery of value-based healthcare
• The benefits and opportunities for the South African Health system, and MedTech (Device, IVD & Medical Software) suppliers
• How value-based procurement has been adopted internationally and lessons learned
• How to create and sustain momentum – including a practical MedTech supplier self-assessment tool

12:00 – 12:30: Unlocking MedTech Data for Market Advantage
Speaker: Saima Kadhila Amoomo – Lead Consultant, Quantium

This session equips members with a clear understanding of how HTA, procurement reform, and data analytics are reshaping buying decisions. You will leave with practical insights to strengthen your value proposition, identify capability gaps, and position your organisation for sustainable relevance in an increasingly evidence-driven procurement landscape.

Who Should Attend

• Market Access Specialists
• MedTech Personnel engaging medical schemes and procurers (public and private sector)
• MedTech Sales and Marketing Personnel

Registration: 
Click here to register